eMedicine Specialties > Dermatology > Diseases of the Dermis

Anetoderma: Treatment & Medication

Author: Anne Laumann, MB, ChB, MRCP(UK), FAAD, Associate Professor, Department of Dermatology, Feinberg School of Medicine, Northwestern University
Coauthor(s): Julia Sanger Minocha, MD, Resident Physician, Department of Medicine, Feinberg School of Medicine, Northwestern University; Stephen C Ho, MD, Boulder Dermatology Clinic
Contributor Information and Disclosures

Updated: Jun 22, 2009

Treatment

Medical Care

No effective treatment for anetoderma is known. Past treatments have included intralesional steroids, penicillin G, aspirin, phenytoin, dapsone, vitamin E, and niacin, with inconsistent results. Anecdotal reports describe topical epsilon-aminocaproic acid (an antifibrinolytic)35 and oral colchicine36 being used to prevent the formation of new inflammatory lesions.

Surgical Care

Surgical excision is an option if lesions are small and few in numbers.

More on Anetoderma

Overview: Anetoderma
Differential Diagnoses & Workup: Anetoderma
Treatment & Medication: Anetoderma
Follow-up: Anetoderma
Multimedia: Anetoderma
References

References

  1. Weinstein S, Piette W. Cutaneous manifestations of antiphospholipid antibody syndrome. Hematol Oncol Clin North Am. Feb 2008;22(1):67-77, vi. [Medline].

  2. Ghomrasseni S, Dridi M, Gogly B, Bonnefoix M, Vabres P, Venencie PY, et al. Anetoderma: an altered balance between metalloproteinases and tissue inhibitors of metalloproteinases. Am J Dermatopathol. Apr 2002;24(2):118-29. [Medline].

  3. Friedman SJ, Venencie PY, Bradley RR, Winkelmann RK. Familial anetoderma. J Am Acad Dermatol. Feb 1987;16(2 Pt 1):341-5. [Medline].

  4. Thomas JE, Mehregan DR, Holland J, Mehregan DA. Familial anetoderma. Int J Dermatol. Jan 2003;42(1):75-7. [Medline].

  5. Zellman GL, Levy ML. Congenital anetoderma in twins. J Am Acad Dermatol. Mar 1997;36(3 Pt 1):483-5. [Medline].

  6. Karrer S, Szeimies RM, Stolz W, Landthaler M. Primary Anetoderma in children: report of two cases and literature review. Pediatr Dermatol. Sep-Oct 1996;13(5):382-5. [Medline].

  7. Taïeb A, Dufillot D, Pellegrin-Carloz B, Calabet A, Clementy J, Guillard JM, et al. Postgranulomatous anetoderma associated with Takayasu's arteritis in a child. Arch Dermatol. Jun 1987;123(6):796-800. [Medline].

  8. Zaki I, Scerri L, Nelson H. Primary anetoderma: phagocytosis of elastic fibres by macrophages. Clin Exp Dermatol. Sep 1994;19(5):388-90. [Medline].

  9. Hodak E, David M. Primary anetoderma and antiphospholipid antibodies--review of the literature. Clin Rev Allergy Immunol. Apr 2007;32(2):162-6. [Medline].

  10. de Souza EM, Daldon PE, Cintra ML. Anetoderma associated with primary antiphospholipid syndrome. J Am Acad Dermatol. May 2007;56(5):881-2. [Medline].

  11. Herrero-Gonzalez JE, Herrero-Mateu C. Primary anetoderma associated with primary Sjogren's syndrome. Lupus. 2002;11(2):124-6. [Medline].

  12. Brenner S, Nemet P, Legum C. Jadassohn-type anetoderma in association with keratoconus and cataract. Ophthalmologica. 1977;174(4):181-4. [Medline].

  13. Brenner S, Gazit E, Lieberman M, Ilie B, Krakowski A. Jadassohn-type anetoderma in association with protrusion of the teeth. Dermatologica. 1980;161(5):334-9. [Medline].

  14. Kasper RC, Wood GS, Nihal M, LeBoit PE. Anetoderma arising in cutaneous B-cell lymphoproliferative disease. Am J Dermatopathol. Apr 2001;23(2):124-32. [Medline].

  15. Jubert C, Cosnes A, Clerici T, Gaulard P, Andre P, Revuz J, et al. Sjogren's syndrome and cutaneous B cell lymphoma revealed by anetoderma. Arthritis Rheum. Jan 1993;36(1):133-4. [Medline].

  16. Peterman A, Scheel M, Sams WM Jr, Pandya AG. Hereditary anetoderma. J Am Acad Dermatol. Dec 1996;35(6):999-1000. [Medline].

  17. de Souza EM, Ayres Vallarelli AF, Cintra ML, Vetter-Kauczok CS, Brocker EB. Anetodermic pilomatricoma. J Cutan Pathol. Aug 18 2008;[Medline].

  18. Clement M, du Vivier A. Anetoderma secondary to syphilis. J R Soc Med. Mar 1983;76(3):223-4. [Medline].

  19. Crone AM, James MP. Acquired linear anetoderma following angular cheilitis. Br J Dermatol. May 1998;138(5):923-4. [Medline].

  20. Cockayne SE, Gawkrodger DJ. Hamartomatous congenital melanocytic nevi showing secondary anetoderma-like changes. J Am Acad Dermatol. Nov 1998;39(5 Pt 2):843-5. [Medline].

  21. Jubert C, Cosnes A, Wechsler J, Andre P, Revuz J, Bagot M. Anetoderma may reveal cutaneous plasmacytoma and benign cutaneous lymphoid hyperplasia. Arch Dermatol. Mar 1995;131(3):365-6. [Medline].

  22. Sheehan DJ, Madkan V, Strickling WA, Peterson CM. Atrophic dermatofibrosarcoma protuberans: a case report and reappraisal of the literature. Cutis. Oct 2004;74(4):237-42. [Medline].

  23. Ozkan S, Fetil E, Izler F, Pabucçuoglu U, Yalcin N, Gunes AT. Anetoderma secondary to generalized granuloma annulare. J Am Acad Dermatol. Feb 2000;42(2 Pt 2):335-8. [Medline].

  24. Daoud MS, Dicken CH. Anetoderma after hepatitis B immunization in two siblings. J Am Acad Dermatol. May 1997;36(5 Pt 1):779-80. [Medline].

  25. Ruiz-Rodriguez R, Longaker M, Berger TG. Anetoderma and human immunodeficiency virus infection. Arch Dermatol. May 1992;128(5):661-2. [Medline].

  26. Trevisan G, Padovan C, Scaini MT, Cinco M, Floris R, Bonin S. Anetoderma associated with lyme disease: a case report. Acta Derm Venereol. 2008;88(5):536-8. [Medline].

  27. Shalders K, Ilchyshyn A, Walzman M. Secondary anetoderma following molluscum contagiosum infection. Acta Derm Venereol. 2003;83(6):461-2. [Medline].

  28. Requena L, Gonzalez-Guerra E, Angulo J, DeVore AE, Sangueza OP. Anetodermic mycosis fungoides: a new clinicopathological variant of mycosis fungoides. Br J Dermatol. Jan 2008;158(1):157-62. [Medline].

  29. Chaby G, Viseux V, Chatelain D, Denoeux JP, Lok C. [Myxofibrosarcoma associated with anetoderma]. Ann Dermatol Venereol. Jan 2006;133(1):35-7. [Medline].

  30. Velez D, Reina Duran T, Perez-Gala S, Fernandez JF. Rosetoid schwannoma (neuroblastoma-like) in association with an anetoderma. J Cutan Pathol. Aug 2006;33(8):573-6. [Medline].

  31. Johnson WC. Wilson's disease and penicillamine-induced anetoderma. Arch Dermatol. 1977;113:976.

  32. Hirschel-Scholz S, Salomon D, Merot Y, Saurat JH. Anetodermic prurigo nodularis (with Pautrier's neuroma) responsive to arotinoid acid. J Am Acad Dermatol. Aug 1991;25(2 Pt 2):437-42. [Medline].

  33. Prizant TL, Lucky AW, Frieden IJ, Burton PS, Suarez SM. Spontaneous atrophic patches in extremely premature infants. Anetoderma of prematurity. Arch Dermatol. Jun 1996;132(6):671-4. [Medline].

  34. Bergman R, Friedman-Birnbaum R, Hazaz B, Cohen E, Munichor M, Lichtig C. An immunofluorescence study of primary anetoderma. Clin Exp Dermatol. Mar 1990;15(2):124-30. [Medline].

  35. Reiss F, Linn E. The therapeutic effect of epsilon-aminocaproic acid on anetoderma Jadassohn. Dermatologica. 1973;146(6):357-60. [Medline].

  36. Braun RP, Borradori L, Chavaz P, Masouye I, French L, Saurat JH. Treatment of primary anetoderma with colchicine. J Am Acad Dermatol. Jun 1998;38(6 Pt 1):1002-3. [Medline].

  37. Aghaei S, Sodaifi M, Aslani FS, Mazharinia N. An unusual presentation of anetoderma: a case report. BMC Dermatol. Aug 19 2004;4:9. [Medline].

  38. Gibson GE, Su WP, Pittelkow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol. Jun 1997;36(6 Pt 1):970-82. [Medline].

  39. Hodak E, Shamai-Lubovitz O, David M, Hazaz B, Katzenelson-Weissman V, Lahav M, et al. Immunologic abnormalities associated with primary anetoderma. Arch Dermatol. Jun 1992;128(6):799-803. [Medline].

  40. Kalogeromitros D, Gregoriou S, Makris M, Georgala S, Kempuraj D, Theoharides TC. Secondary anetoderma associated with mastocytosis. Int Arch Allergy Immunol. 2007;142(1):86-8. [Medline].

  41. Kim JM, Su WP. Mid dermal elastolysis with wrinkling. Report of two cases and review of the literature. J Am Acad Dermatol. Feb 1992;26(2 Pt 1):169-73. [Medline].

  42. Lewis KG, Bercovitch L, Dill SW, Robinson-Bostom L. Acquired disorders of elastic tissue: Part II. decreased elastic tissue. J Am Acad Dermatol. Aug 2004;51(2):165-85; quiz 186-8. [Medline].

  43. Roberts NM, Farrell A, Woodrow D, Leibowitch M, Staughton RC. Anetoderma of Jadassohn-Pellizzari. J R Soc Med. Oct 1995;88(10):599P-600P. [Medline].

  44. Shames BS, Nassif A, Bailey CS, Saltzstein SL. Secondary anetoderma involving a pilomatricoma. Am J Dermatopathol. Oct 1994;16(5):557-60. [Medline].

  45. Stephansson EA, Niemi KM. Antiphospholipid antibodies and anetoderma: are they associated?. Dermatology. 1995;191(3):204-9. [Medline].

  46. Venencie PY, Winkelmann RK, Moore BA. Anetoderma. Clinical findings, associations, and long-term follow-up evaluations. Arch Dermatol. Aug 1984;120(8):1032-9. [Medline].

Further Reading

Keywords

macular atrophy, dermatitis atrophicans maculosa, primary anetoderma, secondary anetoderma

Contributor Information and Disclosures

Author

Anne Laumann, MB, ChB, MRCP(UK), FAAD, Associate Professor, Department of Dermatology, Feinberg School of Medicine, Northwestern University
Anne Laumann, MB, ChB, MRCP(UK), FAAD is a member of the following medical societies: American Academy of Dermatology, Association of Professors of Dermatology, Chicago Dermatological Society, Chicago Medical Society, Illinois Dermatological Society, Illinois State Medical Society, Illinois State Medical Society, Medical Dermatology Society, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Coauthor(s)

Julia Sanger Minocha, MD, Resident Physician, Department of Medicine, Feinberg School of Medicine, Northwestern University
Julia Sanger Minocha, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Stephen C Ho, MD, Boulder Dermatology Clinic
Stephen C Ho, MD is a member of the following medical societies: American Academy of Dermatology, American Contact Dermatitis Society, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, American Society of Cosmetic Dermatology and Aesthetic Surgery, and Colorado Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Peter Fritsch, MD, Chair, Department of Dermatology and Venereology, University of Innsbruck, Austria
Peter Fritsch, MD is a member of the following medical societies: American Dermatological Association, International Society of Pediatric Dermatology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine
Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.